Nahdi Medical Company (4164.SR)
SAR 120.8
(0.0%)
SAR 120.8
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 6.87 SAR | 0.59% |
| 2022 | 6.83 SAR | 9.28% |
| 2021 | 6.25 SAR | -4.29% |
| 2020 | 6.53 SAR | 22.74% |
| 2019 | 5.32 SAR | 13.19% |
| 2018 | 4.70 SAR | -15.32% |
| 2017 | 5.55 SAR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.79 SAR | 36.64% |
| 2024 Q3 | 1.40 SAR | -26.7% |
| 2024 Q2 | 1.91 SAR | 6.7% |
| 2023 Q4 | 1.31 SAR | -20.12% |
| 2023 FY | - SAR | 0.59% |
| 2023 Q3 | 1.64 SAR | -19.61% |
| 2023 Q2 | 2.04 SAR | 8.51% |
| 2023 Q1 | 1.88 SAR | 91.84% |
| 2022 Q2 | 2.07 SAR | 13.11% |
| 2022 Q1 | 1.83 SAR | 66.36% |
| 2022 Q3 | 1.95 SAR | -5.8% |
| 2022 FY | - SAR | 9.28% |
| 2022 Q4 | 0.98 SAR | -49.74% |
| 2021 FY | - SAR | -4.29% |
| 2021 Q4 | 1.10 SAR | -42.11% |
| 2021 Q3 | 1.90 SAR | 9.2% |
| 2021 Q2 | 1.74 SAR | 16.0% |
| 2021 Q1 | 1.50 SAR | 97.37% |
| 2020 Q1 | 2.95 SAR | 0.0% |
| 2020 FY | - SAR | 22.74% |
| 2020 Q4 | 0.76 SAR | -18.28% |
| 2020 Q3 | 0.93 SAR | -65.68% |
| 2020 Q2 | 2.71 SAR | -8.14% |
| 2019 FY | - SAR | 13.19% |
| 2018 FY | - SAR | -15.32% |
| 2017 FY | - SAR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Middle East Pharmaceutical Industries Co. | 3.29 SAR | -108.815% |
| Al-Dawaa Medical Services Company | 3.87 SAR | -77.519% |
| Al-Razi Medical Co. | 0.45 SAR | -1426.667% |
| Almujtama Alraida Medical Co. | 1.20 SAR | -472.5% |